<- Go Home
Moringa Acquisition Corp
As of August 15, 2024, Moringa Acquisition Corp was acquired by Silexion Therapeutics LTD, in a reverse merger transaction. Moringa Acquisition Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It focuses on acquiring technology-based companies in Israel. The company was incorporated in 2020 and is based in New York, New York.
Market Cap
$32.6M
Volume
9.1K
Cash and Equivalents
$17.9K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$13.56
52 Week Low
$8.64
Dividend
N/A
Price / Book Value
-10.81
Price / Earnings
-70.06
Price / Tangible Book Value
-10.81
Enterprise Value
$35.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$971.6K
Return on Equity
18.79%
Return on Assets
-3.63
Cash and Short Term Investments
$17.9K
Debt
$3.3M
Equity
-$3.4M
Revenue
N/A
Unlevered FCF
$20.8M
Sector
Capital Markets
Category
N/A